Staff Profile

Tara Homer is a Senior Lecturer in Health Economics and is the co-theme lead for Economic Analysis Alongside Intervention Studies within the Health Economics Group. Tara is also a Senior Methodological Advisor for the RSS. Tara has an academic background in applied methodological work with a focus on economic evaluation, both within-trial and model-based analyses, and health outcome valuation. This includes working collaboratively in multi-disciplinary teams leading on the design and conduct of economic evaluations and outcome valuation studies alongside randomised controlled trials, in a wide variety of settings such as ENT, dentistry, breast cancer and urology.

Tara has a successfully secured funding from prestigious sources, as a co-applicant, including NIHR HTA. 

Qualifications PhD, Newcastle University, (2017 - present) part-time under staff registration

MSc. Health Economics, University College of Cork – First Class Honours (2012)

BComm (Hons), University College Cork (2011)

Employment history

Senior Research Associate, Population Health Sciences Institute, Newcastle University (April 2020 - March 2024)

Research Associate, Population Health Sciences Institute, Newcastle University (December 2014 - March 2020)

Research Assistant, Institute of Health & Society, Newcastle University (December 2012 - December 2014)

Tara is currently leading the economic evaluation for a number of NIHR HTA trials including; ATNEC, ENHANCE-D, MiTIGATE, POSNOC and VESPER. Tara has expertise in both applied and methodological aspects of health economics and substantial experience working as part of multidisciplinary teams on large national and international projects. Tara has been involved in all aspects of studies, from being a co-applicant on successful grant applications, protocol writing, the development and implementation of study specific data collection tools, analysis plans, costing of interventions, and undertaking the analysis of individual patient-level data and incorporating this data into the economic evaluation of complex randomised controlled trials and economic modelling. She also has experience in preference elicitation and benefit assessment, using methods such as Discrete Choice Experiments, Contingent Valuation, the Patient Generated Index, and methods to derive QALYs (EQ-5D, SF-12, SF-36, GUI).

Tara also provides health economic advice to support grant applications and is a Senior Methodologist Advisor for the RSS. 

Funding

Intravesical Preparations for Recurrent Urinary Tract Infection Prevention (VESPER) – NIHR Health Technology Assessment Programme. Co-applicant. Lead Health Economist. Amount of award £2,021,596.

Newcastle Technology Assessment Review Group (NICE - TARS) – NIHR. Co-applicant. Amount of award £2,925,000.

Managing chronic Myalgia Temporomandibular Disorder (M-TMD): a pragmatic randomised controlled trial of Botulinum toxin type A, Lidocaine, and Amitriptyline/Gabapentin, with internal pilot and cost-effectiveness analysis (MITIGATE) – NIHR Health Technology Assessment Programme. Co-applicant. Lead Health Economist. Amount of award £2,036,276.

Enhancing Dental Health Advice (ENHANCE-D) NIHR Health Technology Assessment Programme. Co-applicant. Amount of award £2,312,082.

Axillary management in T1-3N1M0 breast cancer patients with FNA or core biopsy proven nodal metastases at presentation after NEoadjuvant Chemotherapy (ATNEC) NIHR Health Technology Assessment Programme. Co-applicant, lead health economist. Amount of award £2,998,853.

POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance (POSNOC) NIHR Health Technology Assessment Programme. Collaborator. Amount of award £2,935,418.

Is it possible to develop a complex intervention to improve the outcome of fall-related injuries in people with dementia? (DIFRID). NIHR Health Technology Assessment Programme. Co applicant, lead health economist. Amount of award: £472,809.

Teaching

Deputy Module lead of HSC8027 (2024 - present)

Module lead of HSC8027 (2016-2019)

Public Health MPH, PGDip (2013 - present)

Defined Portfolio Training Session - Newcastle University (2015)

Supervision

Tara has supervised MSc Students from both Newcastle University and York University since 2015.

• Articles

  • Carrie S, Fouweather T, Homer T, O'Hara J, Rousseau N, Rooshenas L, Bray A, Stocken DD, Ternent L, Rennie K, Clark E, Waugh N, Steel AJ, Dooley J, Drinnan M, Hamilton D, Lloyd K, Oluboyede Y, Wilson C, Gardiner Q, Kara N, Khwaja S, Leong SC, Maini S, Morrison J, Nix P, Wilson JA, Teare MD. Effectiveness of septoplasty compared to medical management in adults with obstruction associated with a deviated nasal septum: the NAIROS RCT. Health Technology Assessment 2024, 28(10).
  • King W, Homer T, Harding C, Mossop H, Chadwick T, Abouhajar A, Vale L. Cost-effectiveness of methenamine hippurate compared with antibiotic prophylaxis for the management of recurrent urinary tract infections in secondary care: a multicentre, open-label, randomised, non-inferiority trial. BMJ Open 2024, 14(4), e074445.
  • Wilson JA, Fouweather T, Stocken DD, Homer T, Haighton C, Rousseau N, O'Hara J, Vale L, Wilson R, Carnell S, Wilkes S, Morrison J, Ah-See K, Carrie S, Hopkins C, Howe N, Hussain M, Lindley L, MacKenzie K, McSweeney L, Mehanna H, Raine C, Whelan RS, Sullivan F, von Wilamowitz-Moellendorff A, Teare D. Tonsillectomy compared with conservative management in patients over 16 years with recurrent sore throat: the NATTINA RCT and economic evaluation. Health Technology Assessment 2023, 27(31).
  • Morton M, Wilson N, Homer TM, Simms L, Steel A, Maier R, Wason J, Ternent L, Abouhajar A, Allen M, Joyce R, Hildreth V, Lakey R, Cherlin S, Walker A, Devereux G, Chalmers JD, Hill AT, Haworth C, Hurst JR, De Soyza A. Dual bronchodilators in Bronchiectasis study (DIBS): protocol for a pragmatic, multicentre, placebo-controlled, three-arm, double-blinded, randomised controlled trial studying bronchodilators in preventing exacerbations of bronchiectasis. BMJ Open 2023, 13(8), e071906.
  • Kernohan A, Homer T, Shabaninejad H, King AJ, Hudson J, Fernie G. Cost-effectiveness of primary surgical versus primary medical management in the treatment of patients presenting with advanced glaucoma. British Journal of Ophthalmology 2023, 107(10), 1452-1457.
  • Orozco Leal G, Johnson EE, Hosseinijebeli S, Robinson T, Homer T, Eastaugh C, Richmond C, Tanner L, Meader N, Kenny R, Wallace SA, Rice S. Considerations for the cure assumption in a NICE Single Technology Appraisal of nivolumab with chemotherapy for neoadjuvant treatment of resectable non-small cell lung cancer: Evidence Assessment Group perspective. PharmacoEconomics 2024, 42, 133-136.
  • Wilson JA, O'Hara J, Fouweather T, Homer T, Stocken DD, Vale L, Haighton C, Rousseau N, Wilson R, McSweeney L, Wilkes S, Morrison J, MacKenzie K, Ah-See K, Carrie S, Hopkins C, Howe N, Hussain M, Mehanna H, Raine C, Sullivan F, von Wilamowitz-Moellendorff A, Teare MD. Conservative management versus tonsillectomy in adults with recurrent acute tonsillitis in the UK (NATTINA): a multicentre, open-label, randomised controlled trial. The Lancet 2023, 401(10393), 2051-2059.
  • Carrie S, O'Hara J, Fouweather T, Homer T, Rousseau N, Rooshenas L, Bray A, Stocken DD, Ternent L, Rennie K, Clark E, Waugh N, Steel AJ, Dooley J, Drinnan M, Hamilton D, Lloyd K, Oluboyede Y, Wilson C, Gardiner Q, Kara N, Khwaja S, Leong SC, Maini S, Morrison J, Nix P, Wilson JA, Teare MD. Clinical effectiveness of septoplasty versus medical management for nasal airways obstruction: multicentre, open label, randomised controlled trial. BMJ 2023, 383, e075445.
  • McGovern R, Homer T, Kaner E, Smart D, Ternent L. Preferences for Delivering Brief Alcohol Intervention to Risky Drinking Parents in Children's Social Care: A Discrete Choice Experiment. Alcohol and Alcoholism 2022, 57(5), 615-621.
  • Harding C, Chadwick T, Homer T, Lecouturier J, Mossop H, Carnell S, King W, Abouhajar A, Vale L, Watson G, Forbes R, Currer S, Pickard R, Eardley I, Pearce I, Thiruchelvam N, Guerrero K, Walton K, Hussain Z, Lazarowicz H, Ali A. Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT. Health Technology Assessment 2022, 26(23), 1-172.
  • Harding C, Mossop H, Homer T, Chadwick T, King W, Carnell S, Lecouturier J, Abouhajar A, Vale L, Watson G, Forbes R, Currer S, Pickard R, Eardley I, Pearce I, Thiruchelvam N, Guerrero K, Walton K, Hussain Z, Lazarowicz H, Ali A. Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial. BMJ 2022, 376, e068229.
  • Goyal A, Mann GB, Fallowfield L, Duley L, Reed M, Dodwell D, Coleman RE, Fakis A, Newcombe R, Jenkins V, Whitham D, Childs M, Whynes D, Keeley V, Ellis I, Fairbrother P, Sadiq S, Monson K, Montgomery A, Tan W, Vale L, Homer T, Badger H, Haines RH, Lewis M, Megias D, Nabi Z, Singh P, Caraman A, Miles E. POSNOC-POsitive Sentinel NOde: Adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: A randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes. BMJ Open 2021, 11(12), 054365.
  • Fernandez-Garcia C, Ternent L, Homer T, Rodgers H, Bosomworth H, Shaw L, Aird L, Andole S, Cohen D, Dawson J, Finch T, Ford G, Francis R, Hogg S, Hughes N, Krebs IH, Price C, Turner D, Van Wijck F, Wilkes S, Wilson N, Vale L. Economic evaluation of robot-assisted training versus an enhanced upper limb therapy programme or usual care for patients with moderate or severe upper limb functional limitation due to stroke: results from the RATULS randomised controlled trial. BMJ Open 2021, 11(5), e042081.
  • Homer T, Maguire A, Douglas G, Innes N, Clarkson J, Wilson N, Ryan V, McColl E, Robertson M, Vale L. Cost-effectiveness of child caries management: a randomised controlled trial (FiCTION trial). BMC Oral Health 2020, 20, 45.
  • Innes NP, Clarkson JE, Douglas GVA, Ryan V, Wilson N, Homer T, Marshman Z, McColl E, Vale L, Robertson M, Abouhajar A, Holmes RD, Freeman R, Chadwick B, Deery C, Wong F, Maguire A. Child caries management: a randomized controlled trial in dental practice. Journal of Dental Research 2020, 99(1), 36-43.
  • Maguire A, Clarkson JE, Douglas GVA, Ryan V, Homer T, Marshman Z, McColl E, Wilson N, Vale L, Robertson M, Abouhajar A, Holmes RD, Freeman R, Chadwick B, Deery C, Wong F, Innes NPT. Best-practice prevention alone or with conventional or biological caries management for 3- to 7-year-olds: the FiCTION three-arm RCT. Health Technology Assessment 2020, 24(1), 1-174.
  • Wheatley A, Bamford C, Shaw C, Flynn E, Smith A, Beyer F, Fox C, Barber R, Parry SW, Howel D, Homer TM, Robinson AL, Allan L. Developing an Intervention for Fall-Related Injuries in Dementia (DIFRID): an integrated, mixed-methods approach. BMC Geriatrics 2019, 19, 57.
  • Allan LM, Wheatley A, Smith A, Flynn E, Homer T, Robalino S, Beyer FR, Fox C, Howel D, Barber R, Connolly JA, Robinson L, Parry SW, Rochester L, Corner L, Bamford C. An intervention to improve outcomes of falls in dementia: the DIFRID mixed-methods feasibility study. Health Technology Assessment 2019, 23(59), 1-208.
  • Allan LM, Wheatley A, Flynn E, Smith A, Fox GC, Howel D, Barber R, Homer TM, Robinson AL, Parry SW, Corner L, Connolly J, Rochester L, Bamford C. Is it feasible to deliver a complex intervention to improve the outcome of falls in people with dementia? A protocol for the DIFRID feasibility study. Pilot and Feasibility Studies 2018, 4, 170.
  • Homer T, Shen J, Vale L, McColl E, Tincello DG, Hilton P. Invasive urodynamic testing prior to surgical treatment for stress urinary incontinence in women: cost-effectiveness and value of information analyses in the context of a mixed methods feasibility study. Pilot & Feasibility Studies 2018, 4, 67.
  • Thursz M, Forrest E, Roderick P, Day C, Austin A, O'Grady J, Ryder A, Allison M, Gleeson D, McCune A, Patch D, Wright M, Masson S, Richardson P, Hood S, MacGilchrist A, Grant A, Vale L, Mellor J, Stanton L, Bowers M, Ratcliffe I, Downs N, Kirkman S, Homer T, Ternent L, Deverill M. The clinical effectiveness and cost-effectiveness of STeroids or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2x2 factorial, randomised controlled trial. Health Technology Assessment 2015, 19(102).
  • Stewart M, Keightley A, Maguire A, Chadwick B, Vale L, Homer T, Douglas G, Deery C, Marshman Z, Ryan V, Innes N. Investigating the management of carious primary teeth in general dental practice: an overview of the development and conduct of the Fiction Trial. Primary Dental Journal 2015, 4(4), 67-73.
  • Hilton P, Armstrong N, Brennand C, Howel D, Shen J, Bryant A, Tincello DG, Lucas MG, Buckley BS, Chapple CR, Homer T, Vale L, McColl E. INVESTIGATE-I (INVasive Evaluation before Surgical Treatment of Incontinence Gives Added Therapeutic Effect?): a mixed methods study to assess the feasibility of a future randomised controlled trial of invasive urodynamic testing prior to surgery for stress urinary incontinence in women. Health Technology Assessment 2015, 19(15).
  • Hilton P, Armstrong N, Brennand C, Howel D, Shen J, Bryant A, Tincello DG, Lucas MG, Buckley BS, Chapple CR, Homer T, Vale L, McColl E. A mixed methods study to assess the feasibility of a randomized controlled trial of invasive urodynamic testing versus clinical assessment and non-invasive tests prior to surgery for stress urinary incontinence in women: the INVESTIGATE-I study. Trials 2015, 16, 400.
  • Orr J, Homer T, Ternent L, Vale L, Hudson M, Jones D. PTU-112 Associations Between Healthcare Resource Utilisation And Health-related Quality Of Life In Cirrhosis. Gut 2014, 63(Suppl. 1), A88-A88.
  • Orr J G., Homer T, Ternent L, Newton J, McNeil C J., Hudson M, Jones D E.J. 'Health Related Quality of Life in People with Advanced Chronic Liver Disease'. Journal of Hepatology 2014, 61(5), 1158–1165.
  • Hilton P, Armstrong N, Brennand C, Howel D, Shen J, Bryant A, Tincello DG, Lucas MG, Buckley BS, Chapple CR, Homer T, McColl E. A mixed methods study to assess the feasibility of a future randomised controlled trial of invasive urodynamic testing prior to surgery for urinary incontinence in women. International Urogynecology Journal & Pelvic Floor Dysfunction 2014, 25(1), S182-S183.
  • Hilton P, Armstrong N, Brennand C, Howel D, Shen J, Bryant A, Tincello DG, Lucas MG, Buckley BS, Chapple CR, Homer T, McColl E. A mixed methods study to assess the feasibility of a future randomised controlled trial of invasive urodynamic testing prior to surgery for stress urinary incontinence in women. Female Pelvic Medicine & Reconstructive Surgery 2014, 20(4(supp.1)), S106-S107.

• Conference Proceedings (inc. Abstract)

  • Homer T, Vale L, Shen J, Hilton P. Cost-Utility And Value Of Information (Voi) Analyses On The Feasibility Of A Future Randomised Controlled Trial (Rct) Of Invasive Urodynamic Testing Prior To Surgery For Stress Urinary Incontinence In Women. In: ISPOR 17th Annual European Congress. 2014, Amsterdam, The Netherlands: Elsevier.

• Letter

  • Hilton P, Bryant A, Howel D, McColl E, Shen J, Homer T, Vale L, Buckley BS, Lucas MG, Tincello DG, Armstrong N. Letter to the editor re: Assessing professional equipoise and views about a future clinical trial of invasive urodynamics prior to surgery for stress urinary incontinence in women: A survey within a mixed methods feasibility study. Neurourol Urodyn. 2012;31(8):1223-30. Neurourology and Urodynamics 2016, 35(6), 750-751.

• Review

  • Orr JG, Homer T, Ternent L, Newton J, McNeil CJ, Hudson M, Jones DEJ. Health related quality of life in people with advanced chronic liver disease. Journal of Hepatology 2014, 61(5), 1158-1165.